ML18198A333
| ML18198A333 | |
| Person / Time | |
|---|---|
| Site: | 03001590 |
| Issue date: | 07/17/2018 |
| From: | Frazier C F NRC/RGN-III |
| To: | St. Catherine Hosp |
| References | |
| 608560 | |
| Download: ML18198A333 (3) | |
Text
NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 3 PAGES Amendment No. 74 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee 1. St. Catherine Hospital, Inc. 2. 4321 Fir St. East Chicago, IN 46312 6. Byproduct, source, 7. and/or special nuclear material A. Any byproduct material A. permitted by 10 CFR 35.100 B. Any byproduct material B. permitted by 10 CFR 35.200 C. Any byproduct material C. permitted by 10 CFR 35.300 D. Any byproduct material D. permitted by 10 CFR 31.11 Chemical alff:t,or physical Any Any Any Prepackaged Kits In accordance with letter dated 4. Expiration Date: November 30, 2025 April 1 t-----------.i!i-~--1
- 5. Docket No.: 030-01590 Reference No.: ,:,;,!f. Ma~ount that lice1liee
- 9. Authorized use A. For use in uptake, dilution and excretion studies permitted by 10 CFR 35.100. B. For use in imaging and localization studies permitted by 10 CFR 35.200. C. 1 curie total C. For any use permitted by 10 CFR )",.-'-'~
"~. 35.300. D. 5 millicuries total D. For use in in-vitro studies. CONDITIONS NRC FORM 374A MATERIALS LICENSE SUPPLEMENTARY SHEET U.S. NUCLEAR REGULATORY COMMISSION License Number 13-01148-01 Amendment No. 74 Docket or Reference Number 030-01590 PAGE 2 OF 3 PAGES 10. Licensed material may be used or stored at the licensee's facilities located at 4321 Fir St., East Chicago, Indiana, 46312. 11. The Radiation Safety Officer (RSO) for this license is rWli,..,l~.
Bt.iu. 0 12. Licensed material shall only be used by, or l!Ad)r the supervision of: A Individuals permitted to work as auth'9ed u IJj B. The fol.lowing individuals are autho'd users ~o .. Authorized User(M.D.,0.0.,etc.)
Material 1 Ravi S. Bhagwat, M.D. 10JJFR 3 Miquel Gambetta, M.D. John W. Gustaitis, Jr., M.D. Thomas M. Hoess, M.D. Mikhail Jeha, M.D. Shawn R. Kenney, M.D. Mohan Kesani, M.D. Sorin Lazar, M.D. Jonathon T. Lee, M.D. Mary Nicholson, M.D. Charles-Lauwanga Okoro, D.O. Thomas Shin, M.D. Justin Spackey, M.D. Ramana Yedavalli, M.D. Andrej Zajac, M.D. 10 CFR 35.100 and 35.200 10 CFR 35.200 10 CFR 35.100 and 35.200 10 CFR 35.100 and 35.200 10 CFR 35.100 and 35.200 10 CFR 35.300 NRC FORM 374A MATERIALS LICENSE SUPPLEMENTARY SHEET Authorized User(M.D.,D.O.,etc.)
U.S. NUCLEAR REGULATORY COMMISSION License Number 13-01148-01 Amendment No. 74 Material and Use Docket or Reference Number 030-01590 PAGE 3 OF 3 PAGES Feng Zhang, M.D. 10 CFR 35.100, 35.~ ~.300 (limited to oral administration of sodium iodide 1-131 in quantities of 33 milljp~~p\
19")1: G ; ffi *~ ,A:'.) 13. Except as specifically provided otherwise in t~i~,J~rise, the licensee shall condu6' ~_erogram in accordance with the statements, representations, and procedures contained~
documents, including any enclosur~isted below. This license condition applies only to those procedures that are required to be suoiiitted in accordance with the regulation~.
~itionally, this license condition does not limit the licensee's ability to make changes to the GgliatioH ction program as provi ** tin 1~FR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall_g~vern J.t,ss the . ts, repre!entati
- . proce~s in the licensee's application and correspondence are more restrictive th~he regulatl' q ,
- A. Application dated June 3, 2015 (M~159A392)
\. B. Letter dated October 23, 2015 (ML~OOA5~)
ti) Date: JUL 1 7)0\8